Year To Quarter End Consolidated Statement Of Income

Kidswell Bio Corporation - Filing #7297119

Concept 2024-04-01 to
2024-09-30
Year to quarter end consolidated statement of income
Statement of income
Net sales
1,749,911,000 JPY
Cost of sales
1,257,582,000 JPY
Gross profit (loss)
492,329,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
754,850,000 JPY
Operating profit (loss)
-262,520,000 JPY
Non-operating income
Interest income
122,000 JPY
Non-operating income
23,224,000 JPY
Non-operating expenses
Interest expenses
21,141,000 JPY
Non-operating expenses
28,697,000 JPY
Ordinary profit (loss)
-267,993,000 JPY
Extraordinary income
Extraordinary income
42,099,000 JPY
Extraordinary losses
Extraordinary losses
14,999,000 JPY
Profit (loss) before income taxes
-240,894,000 JPY
Income taxes - current
900,000 JPY
Income taxes
900,000 JPY
Profit (loss)
-241,794,000 JPY
Profit attributable to
Profit (loss) attributable to owners of parent
-241,794,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
100,196,000 JPY
Other comprehensive income
100,196,000 JPY
Comprehensive income
-141,598,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-141,598,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.